EP3612201
ONCOLYTIC VACCINIA VIRUS AND CHECKPOINT INHIBITOR COMBINATION THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.4.2018EP published:
25.10.2023EP application number:
18723290.5
EPO information:
European Patent Register
Max expiry date:
22.4.2038
Title in English:
ONCOLYTIC VACCINIA VIRUS AND CHECKPOINT INHIBITOR COMBINATION THERAPYLanguage of the patent:
English
Timeline
Today
23.4.2018EP application
25.10.2023EP Publication
Owner
Name:
Sillajen, Inc.Address:
607-ho 6F 111 Hyoyeol-ro Buk-gu, Busan 46508, KR
Inventor
Name:
KIM, ChanAddress:
Busan 46508, KR
Name:
JEON, HongjaeAddress:
Busan 46508, KR
Name:
MOON, Eun, SangAddress:
Busan 46508, KR
Name:
CHI, SungkuonAddress:
Busan 46508, KR
Name:
CHOI, Jiwon, SarahAddress:
Busan 46508, KR
Name:
JUNG, Joon-gooAddress:
Busan 46508, KR
Name:
BAE, JunguAddress:
Busan 46508, KR
Priority
Number:
201762488623 PDate:
21.4.2017Country:
US
Number:
201762550486 PDate:
25.8.2017Country:
US
Classification
Categories:
A61K 35/768, A61K 39/395, A61P 35/00